Novan Further Expands its Proprietary Nitric Oxide Platform
18 oct. 2019 08h30 HE
|
Novan, Inc.
A new product candidate, SB207, to target anti-viral opportunitiesPre-IND meeting anticipated in December 2019Development of SB207 to be focused on indications with unmet patient need, such as...